Jeil Pharmaceutical Co.,Ltd (KRX: 271980)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,450
-320 (-2.72%)
Dec 20, 2024, 3:30 PM KST

Jeil Pharmaceutical Co.,Ltd Revenue

Jeil Pharmaceutical Co.,Ltd had revenue of 174.38B KRW in the quarter ending September 30, 2024, a decrease of -1.59%. This brings the company's revenue in the last twelve months to 697.64B, down -2.86% year-over-year. In the year 2023, Jeil Pharmaceutical Co.,Ltd had annual revenue of 726.39B with 0.58% growth.

Revenue (ttm)
697.64B
Revenue Growth
-2.86%
P/S Ratio
0.24
Revenue / Employee
697.64M
Employees
1,000
Market Cap
166.84B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023726.39B4.16B0.58%
Dec 31, 2022722.23B21.54B3.07%
Dec 31, 2021700.69B9.37B1.36%
Dec 31, 2020691.32B19.92B2.97%
Dec 31, 2019671.41B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition